MARKET INSIGHTS
Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody market size was valued at USD 450 million in 2024. The market is projected to grow from USD 510 million in 2025 to USD 1066 million by 2032, exhibiting a CAGR of 13.4% during the forecast period.
Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody is a specialized protein that specifically targets the COX-2 enzyme, which plays a crucial role in inflammatory responses and disease progression. These antibodies are essential research tools for studying inflammation pathways and have significant applications in drug development and clinical diagnostics.
The market growth is driven by increasing research in inflammatory diseases and cancer therapeutics, where COX-2 overexpression is frequently observed. Rising investment in biotechnology R&D and growing demand for targeted therapies are accelerating market expansion. Recent advancements in antibody production technologies and increasing adoption in academic research further contribute to this growth. Key players like Abcam, Thermo Fisher Scientific, and Merck are expanding their product portfolios to meet the growing demand for high-specificity COX-2 antibodies in research applications.
MARKET DYNAMICS
MARKET DRIVERS
Rising Prevalence of Chronic Inflammatory Diseases to Fuel COX-2 Antibody Demand
The global increase in chronic inflammatory conditions such as arthritis, cardiovascular diseases, and cancers is a significant driver for the COX-2 antibody market. Epidemiological data indicates over 350 million people worldwide suffer from osteoarthritis alone, with numbers expected to grow due to aging populations and lifestyle factors. COX-2 antibodies play a crucial role in research studies investigating inflammatory pathways, as they help detect and quantify COX-2 protein expression levels. Pharmaceutical companies are increasingly utilizing these antibodies in drug discovery programs targeting inflammation-mediated disorders, creating sustained demand across academic, clinical, and industrial research applications.
Advances in Oncology Research Accelerate Market Expansion
The growing emphasis on cancer research presents significant opportunities for COX-2 antibodies, given the enzyme's established role in tumor progression. Recent studies demonstrate COX-2 overexpression in approximately 40% of invasive breast cancers and 80-90% of colorectal cancers. These findings have spurred pharmaceutical R&D investment in COX-2 targeted therapies, with monoclonal antibodies being particularly valuable for both diagnostic and therapeutic applications. The expanding immuno-oncology sector, projected to maintain double-digit growth through 2030, continues to incorporate COX-2 analysis in biomarker discovery and validation workflows, driving consistent market demand.
➤ The monoclonal antibody segment accounted for approximately 62% of total market share in 2024, reflecting strong preference for high-specificity reagents in research applications.
Additionally, technological advancements in antibody production and validation processes have improved product quality and consistency, reducing batch-to-batch variability concerns that previously hindered research reproducibility.
MARKET RESTRAINTS
Regulatory Complexities Create Adoption Barriers
The COX-2 antibody market faces substantial regulatory hurdles that slow product commercialization and adoption. Antibody-based research reagents must comply with stringent quality standards across multiple jurisdictions, with validation requirements varying significantly between regions. These regulatory complexities particularly affect smaller manufacturers lacking resources for extensive documentation and compliance procedures. Furthermore, the absence of universal standardization for antibody validation protocols creates uncertainty among end-users, potentially delaying procurement decisions.
High Development Costs Constrain Market Growth
Production of research-grade antibodies involves substantial capital investment, with monoclonal antibody development averaging 6-18 months and costing approximately $50,000-$500,000 per project depending on complexity. These costs are compounded by ongoing expenses related to quality control, stability testing, and technical support. Such financial barriers limit market entry for new competitors and potentially restrict product accessibility for budget-constrained research institutions, particularly in developing regions where funding for basic research remains limited.
MARKET CHALLENGES
Cross-Reactivity Issues Hinder Research Applications
A primary technical challenge facing the COX-2 antibody market involves specificity concerns, where certain products demonstrate cross-reactivity with similar epitopes or related proteins. This issue is particularly problematic for polyclonal antibodies, where batch variability can affect experimental outcomes. Studies indicate approximately 30-40% of commercially available research antibodies may fail specificity validation in common applications like Western blotting or immunohistochemistry, raising concerns about data reliability and reproducibility.
Other Challenges
Storage and Stability Limitations
Proper antibody storage at -20°C to -80°C with appropriate preservatives presents logistical challenges for end-users, particularly in resource-limited settings where reliable cold chain infrastructure may be unavailable. Improper handling can reduce product efficacy, potentially invalidating research results and creating additional costs through repeated experiments.
Intellectual Property Disputes
Patent conflicts surrounding antibody production technologies occasionally restrict market competition and innovation. Several major manufacturers have engaged in lengthy litigation over proprietary cloning techniques and epitope sequences, creating uncertainty that may temporarily disrupt supply chains.
MARKET OPPORTUNITIES
Emerging Markets Offer Significant Growth Potential
Developing regions present substantial untapped opportunities, with Asia-Pacific's research expenditure growing at approximately 15% annually compared to 4-6% in mature markets. Countries including China, India, and South Korea are making significant investments in biomedical research infrastructure, creating demand for high-quality research reagents. Local antibody manufacturers are increasingly partnering with international distributors to expand market reach, while multinational corporations establish regional production facilities to better serve these growing markets.
Custom Antibody Services Generate New Revenue Streams
The growing trend toward specialized research applications has driven increased demand for custom antibody development services. Many market leaders now offer bespoke solutions including recombinant antibodies, multiplex assay-compatible formats, and species-specific variants. This service-oriented approach commands premium pricing while fostering long-term client relationships, with the custom antibody segment growing nearly 20% year-over-year as researchers require reagents tailored to emerging experimental needs.
Segment Analysis:
By Type
Monoclonal Antibody Segment Leads Due to High Specificity in Research Applications
The market is segmented based on type into:
-
Monoclonal Antibody
-
Polyclonal Antibody
By Application
Western Blot Segment Dominates Owing to Widespread Usage in Protein Analysis
The market is segmented based on application into:
-
Flow Cytometry
-
ELISA
-
Western Blot
-
Immunoprecipitation
-
Immunofluorescence
-
Others
By End User
Pharmaceutical & Biotechnology Companies Lead Due to Extensive R&D Activities
The market is segmented based on end user into:
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutes
-
Hospitals & Diagnostic Centers
-
Contract Research Organizations
COMPETITIVE LANDSCAPE
Key Industry Players
Innovation and Strategic Expansion Define Market Leadership in COX-2 Antibody Space
The global COX-2 antibody market demonstrates a fragmented yet dynamic competitive environment, with established biotech firms and specialized antibody manufacturers vying for market share. Abcam plc has emerged as a frontrunner, capturing approximately 18% of the global revenue share in 2024, owing to its extensive catalog of high-specificity COX-2 antibodies and strong distribution partnerships across academic and pharmaceutical research sectors.
Thermo Fisher Scientific maintains a dominant position through its vertically integrated supply chain and comprehensive portfolio of research tools, while Cell Signaling Technology has gained significant traction with its clinically validated antibodies optimized for precision applications in oncology research.
Meanwhile, Asia-based manufacturers like Wuhan Fine Biotech and Sino Biological are disrupting traditional market dynamics through cost-competitive offerings, collectively accounting for nearly 22% of the APAC market. These players leverage regional manufacturing advantages while progressively improving antibody specificity and batch-to-batch consistency.
Notably, the market has witnessed intensified M&A activity, with Bio-Techne's 2023 acquisition of Novus Biologicals significantly expanding its COX-2 antibody capabilities. Such strategic consolidations enable companies to combine technological expertise while broadening their geographic footprints in high-growth emerging markets.
List of Key Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Players
- Abcam plc (UK)
- Cell Signaling Technology, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Sino Biological, Inc. (China)
- Bio-Techne Corporation (U.S.)
- Merck KGaA (Germany)
- Wuhan Fine Biotech Co., Ltd. (China)
- GeneTex International Corporation (U.S.)
- MyBiosource, Inc. (U.S.)
- Arigo Biolaboratories Corp. (Taiwan)
- Cayman Chemical Company (U.S.)
- Enzo Life Sciences, Inc. (U.S.)
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2 (COX-2) ANTIBODY MARKET TRENDS
Increasing Research in Cancer Therapeutics to Drive COX-2 Antibody Demand
The global COX-2 antibody market is witnessing significant growth due to expanding research in cancer therapeutics, particularly targeting inflammation-associated malignancies. COX-2 overexpression has been identified in approximately 40-50% of colorectal cancers and 80% of invasive breast cancers, creating substantial demand for reliable detection antibodies. Recent advancements in immunohistochemistry techniques have improved the specificity of COX-2 antibody applications, enabling more accurate tumor profiling. Pharmaceutical companies are increasingly investing in COX-2 targeted therapies, with over 15 clinical trials currently evaluating COX-2 inhibitors for various oncology applications, further propelling antibody utilization in drug development pipelines.
Other Trends
Technological Advancements in Antibody Production
The market is experiencing a shift toward recombinant antibody technologies, offering superior batch-to-batch consistency compared to traditional polyclonal preparations. Leading manufacturers are adopting phage display and hybridoma-based methods to develop high-affinity monoclonal COX-2 antibodies with minimal cross-reactivity. These innovations are particularly valuable for research requiring precise quantification of COX-2 expression levels in complex biological samples. The monoclonal antibody segment currently accounts for approximately 65% of market share due to these technical advantages.
Expanding Applications in Neurological Research
Growing evidence of COX-2 involvement in neuroinflammatory processes has opened new avenues for antibody applications in neuroscience. Research indicates COX-2 plays a critical role in neurodegenerative conditions like Alzheimer's disease and Parkinson's disease, where it contributes to neuroinflammation and neuronal damage. The neuroscience segment is projected to grow at a 15.2% CAGR through 2032, driven by increasing government funding for neurological disorder research. Pharmaceutical companies are also exploring COX-2 antibody-based diagnostics for early detection of inflammatory markers in cerebrospinal fluid, creating additional market opportunities.
Regional Analysis: Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market
North America
The North American COX-2 antibody market is characterized by strong research investments and advanced healthcare infrastructure, particularly in the U.S. where major pharmaceutical and biotechnology companies drive demand. The region accounted for approximately 38% of global COX-2 antibody revenue in 2024, owing to high research funding from both private and public sectors. While monoclonal antibodies dominate research applications, there's increasing demand for polyclonal variants in diagnostic applications. Regulatory bodies like the FDA have accelerated approvals for COX-2 targeted therapies, particularly in oncology and inflammatory disease research. However, pricing pressures from healthcare cost containment measures pose challenges for market growth.
Europe
Europe represents the second-largest market for COX-2 antibodies, with Germany and the U.K. leading in academic and clinical research applications. The region benefits from strong government funding for inflammatory disease research and well-established pharmaceutical collaborations. Western blot and ELISA applications account for nearly 60% of regional demand, reflecting the emphasis on diagnostic validation. While the market is mature, growth is sustained through innovations in recombinant antibody technologies and increasing partnerships between academic institutions and biotech firms. Brexit-related regulatory uncertainties continue to create some supply chain complexities for UK-based researchers.
Asia-Pacific
Asia-Pacific is the fastest-growing COX-2 antibody market, projected to grow at over 16% CAGR through 2032, driven by expanding life science research capabilities in China, Japan, and India. China's biopharma sector is aggressively developing domestic antibody production capabilities to reduce import dependence. While cost sensitivity favors polyclonal antibody adoption, there's rising demand for high-specificity monoclonal antibodies from multinational pharmaceutical companies establishing R&D centers in the region. Challenges include inconsistent antibody quality standards across countries and intellectual property concerns that hinder technology transfer. India's contract research organizations are emerging as significant consumers for validation-grade COX-2 antibodies.
South America
The South American market remains nascent but shows potential, particularly in Brazil and Argentina where government initiatives support local biotech development. Research applications currently focus on academic institutions rather than commercial drug development, leading to preference for mid-range priced polyclonal antibodies. Market growth is constrained by limited research funding, currency volatility affecting import costs, and underdeveloped distribution networks. However, increasing prevalence of chronic inflammatory diseases and oncology research partnerships with global pharmaceutical companies indicate future expansion opportunities.
Middle East & Africa
This region represents a developing market where COX-2 antibody adoption is primarily concentrated in South Africa, Israel, and select Gulf Cooperation Council countries with advanced medical research facilities. Market growth is fueled by rising healthcare investments and increasing focus on precision medicine initiatives. Israel's strong biotechnology sector drives innovation in antibody applications, while GCC nations are investing in research infrastructure. Challenges include limited local manufacturing capabilities and reliance on imports, though regional players are beginning to establish partnerships with global antibody suppliers to improve accessibility.
Report Scope
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Key Coverage Areas:
FREQUENTLY ASKED QUESTIONS:
What is the current market size of Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market?
-> The Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody market was valued at USD 450 million in 2024 and is projected to reach USD 1066 million by 2032.
Which key companies operate in Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market?
-> Key players include Sino Biological, Inc., Abcam, Thermo Fisher Scientific, Merck, Cell Signaling Technology, Bio-Techne, and GeneTex, among others.
What are the key growth drivers?
-> Key growth drivers include rising prevalence of inflammatory diseases and cancers, increasing R&D investments in life sciences, and growing applications in drug development and diagnostics.
Which region dominates the market?
-> North America currently holds the largest market share, while Asia-Pacific is expected to witness the highest growth rate during the forecast period.
What are the emerging trends?
-> Emerging trends include development of high-specificity antibodies, increasing adoption of automated antibody production technologies, and growing focus on personalized medicine applications.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Overall Market Size
2.1 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size: 2024 VS 2032
2.2 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales: 2020-2032
3 Company Landscape
3.1 Top Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Players in Global Market
3.2 Top Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Companies Ranked by Revenue
3.3 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue by Companies
3.4 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales by Companies
3.5 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Type
3.8 Tier 1, Tier 2, and Tier 3 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Players in Global Market
3.8.1 List of Global Tier 1 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size Markets, 2024 & 2032
4.1.2 Monoclonal Antibody
4.1.3 Polyclonal Antibody
4.2 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue & Forecasts
4.2.1 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2025
4.2.2 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2026-2032
4.2.3 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales & Forecasts
4.3.1 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2025
4.3.2 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2026-2032
4.3.3 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
4.4 Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2024 & 2032
5.1.2 Flow Cytometry
5.1.3 ELISA
5.1.4 Western Blot
5.1.5 Immunoprecipitation
5.1.6 Immunofluorescence
5.1.7 Others
5.2 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue & Forecasts
5.2.1 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2025
5.2.2 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2026-2032
5.2.3 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales & Forecasts
5.3.1 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2025
5.3.2 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2026-2032
5.3.3 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
5.4 Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2024 & 2032
6.2 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue & Forecasts
6.2.1 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2025
6.2.2 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2026-2032
6.2.3 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
6.3 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales & Forecasts
6.3.1 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2025
6.3.2 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2026-2032
6.3.3 By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2032
6.4.2 By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2032
6.4.3 United States Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.4.4 Canada Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.4.5 Mexico Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2032
6.5.2 By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2032
6.5.3 Germany Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5.4 France Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5.5 U.K. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5.6 Italy Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5.7 Russia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5.8 Nordic Countries Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.5.9 Benelux Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2032
6.6.2 By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2032
6.6.3 China Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.6.4 Japan Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.6.5 South Korea Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.6.6 Southeast Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.6.7 India Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2032
6.7.2 By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2032
6.7.3 Brazil Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.7.4 Argentina Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, 2020-2032
6.8.3 Turkey Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.8.4 Israel Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.8.5 Saudi Arabia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
6.8.6 UAE Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Company Summary
7.1.2 Sino Biological, Inc. Business Overview
7.1.3 Sino Biological, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.1.4 Sino Biological, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.1.5 Sino Biological, Inc. Key News & Latest Developments
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Company Summary
7.2.2 LifeSpan BioSciences, Inc Business Overview
7.2.3 LifeSpan BioSciences, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.2.4 LifeSpan BioSciences, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.2.5 LifeSpan BioSciences, Inc Key News & Latest Developments
7.3 Abcam
7.3.1 Abcam Company Summary
7.3.2 Abcam Business Overview
7.3.3 Abcam Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.3.4 Abcam Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.3.5 Abcam Key News & Latest Developments
7.4 Cell Signaling Technology, Inc.
7.4.1 Cell Signaling Technology, Inc. Company Summary
7.4.2 Cell Signaling Technology, Inc. Business Overview
7.4.3 Cell Signaling Technology, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.4.4 Cell Signaling Technology, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.4.5 Cell Signaling Technology, Inc. Key News & Latest Developments
7.5 Thermo Fisher Scientific (China) Co., Ltd.
7.5.1 Thermo Fisher Scientific (China) Co., Ltd. Company Summary
7.5.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
7.5.3 Thermo Fisher Scientific (China) Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.5.4 Thermo Fisher Scientific (China) Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.5.5 Thermo Fisher Scientific (China) Co., Ltd. Key News & Latest Developments
7.6 Bio-Techne
7.6.1 Bio-Techne Company Summary
7.6.2 Bio-Techne Business Overview
7.6.3 Bio-Techne Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.6.4 Bio-Techne Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.6.5 Bio-Techne Key News & Latest Developments
7.7 Arigo Biolaboratories Corp.
7.7.1 Arigo Biolaboratories Corp. Company Summary
7.7.2 Arigo Biolaboratories Corp. Business Overview
7.7.3 Arigo Biolaboratories Corp. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.7.4 Arigo Biolaboratories Corp. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.7.5 Arigo Biolaboratories Corp. Key News & Latest Developments
7.8 Cayman Chemical
7.8.1 Cayman Chemical Company Summary
7.8.2 Cayman Chemical Business Overview
7.8.3 Cayman Chemical Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.8.4 Cayman Chemical Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.8.5 Cayman Chemical Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.9.4 Merck Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.9.5 Merck Key News & Latest Developments
7.10 Enzo Life Sciences, Inc.
7.10.1 Enzo Life Sciences, Inc. Company Summary
7.10.2 Enzo Life Sciences, Inc. Business Overview
7.10.3 Enzo Life Sciences, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.10.4 Enzo Life Sciences, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.10.5 Enzo Life Sciences, Inc. Key News & Latest Developments
7.11 GeneTex
7.11.1 GeneTex Company Summary
7.11.2 GeneTex Business Overview
7.11.3 GeneTex Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.11.4 GeneTex Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.11.5 GeneTex Key News & Latest Developments
7.12 Wuhan Fine Biotech Co., Ltd.
7.12.1 Wuhan Fine Biotech Co., Ltd. Company Summary
7.12.2 Wuhan Fine Biotech Co., Ltd. Business Overview
7.12.3 Wuhan Fine Biotech Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.12.4 Wuhan Fine Biotech Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.12.5 Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
7.13 MyBiosource, Inc.
7.13.1 MyBiosource, Inc. Company Summary
7.13.2 MyBiosource, Inc. Business Overview
7.13.3 MyBiosource, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.13.4 MyBiosource, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.13.5 MyBiosource, Inc. Key News & Latest Developments
7.14 Biocare Medical, LLC
7.14.1 Biocare Medical, LLC Company Summary
7.14.2 Biocare Medical, LLC Business Overview
7.14.3 Biocare Medical, LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.14.4 Biocare Medical, LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.14.5 Biocare Medical, LLC Key News & Latest Developments
7.15 Abbexa
7.15.1 Abbexa Company Summary
7.15.2 Abbexa Business Overview
7.15.3 Abbexa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.15.4 Abbexa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.15.5 Abbexa Key News & Latest Developments
7.16 Biorbyt
7.16.1 Biorbyt Company Summary
7.16.2 Biorbyt Business Overview
7.16.3 Biorbyt Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.16.4 Biorbyt Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.16.5 Biorbyt Key News & Latest Developments
7.17 Elabscience Biotechnology Inc.
7.17.1 Elabscience Biotechnology Inc. Company Summary
7.17.2 Elabscience Biotechnology Inc. Business Overview
7.17.3 Elabscience Biotechnology Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.17.4 Elabscience Biotechnology Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.17.5 Elabscience Biotechnology Inc. Key News & Latest Developments
7.18 Boster Biological Technology
7.18.1 Boster Biological Technology Company Summary
7.18.2 Boster Biological Technology Business Overview
7.18.3 Boster Biological Technology Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.18.4 Boster Biological Technology Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.18.5 Boster Biological Technology Key News & Latest Developments
7.19 RevMAb Biosciences USA, Inc
7.19.1 RevMAb Biosciences USA, Inc Company Summary
7.19.2 RevMAb Biosciences USA, Inc Business Overview
7.19.3 RevMAb Biosciences USA, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.19.4 RevMAb Biosciences USA, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.19.5 RevMAb Biosciences USA, Inc Key News & Latest Developments
7.20 Abeomics Inc.
7.20.1 Abeomics Inc. Company Summary
7.20.2 Abeomics Inc. Business Overview
7.20.3 Abeomics Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.20.4 Abeomics Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.20.5 Abeomics Inc. Key News & Latest Developments
7.21 OriGene Technologies, Inc.
7.21.1 OriGene Technologies, Inc. Company Summary
7.21.2 OriGene Technologies, Inc. Business Overview
7.21.3 OriGene Technologies, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.21.4 OriGene Technologies, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.21.5 OriGene Technologies, Inc. Key News & Latest Developments
7.22 Signalway Antibody LLC
7.22.1 Signalway Antibody LLC Company Summary
7.22.2 Signalway Antibody LLC Business Overview
7.22.3 Signalway Antibody LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Major Product Offerings
7.22.4 Signalway Antibody LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales and Revenue in Global (2020-2025)
7.22.5 Signalway Antibody LLC Key News & Latest Developments
8 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production Capacity, Analysis
8.1 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production Capacity, 2020-2032
8.2 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Supply Chain Analysis
10.1 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Industry Value Chain
10.2 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Upstream Market
10.3 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody in Global Market
Table 2. Top Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Share by Companies, 2020-2025
Table 5. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales by Companies, (K Units), 2020-2025
Table 6. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Type
Table 9. List of Global Tier 1 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 21. By Region � Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 25. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 26. By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 29. By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 30. By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 33. By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 34. By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 37. By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 38. By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 41. By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, (K Units), 2026-2032
Table 46. Sino Biological, Inc. Company Summary
Table 47. Sino Biological, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 48. Sino Biological, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Sino Biological, Inc. Key News & Latest Developments
Table 50. LifeSpan BioSciences, Inc Company Summary
Table 51. LifeSpan BioSciences, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 52. LifeSpan BioSciences, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. LifeSpan BioSciences, Inc Key News & Latest Developments
Table 54. Abcam Company Summary
Table 55. Abcam Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 56. Abcam Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Abcam Key News & Latest Developments
Table 58. Cell Signaling Technology, Inc. Company Summary
Table 59. Cell Signaling Technology, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 60. Cell Signaling Technology, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Cell Signaling Technology, Inc. Key News & Latest Developments
Table 62. Thermo Fisher Scientific (China) Co., Ltd. Company Summary
Table 63. Thermo Fisher Scientific (China) Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 64. Thermo Fisher Scientific (China) Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Thermo Fisher Scientific (China) Co., Ltd. Key News & Latest Developments
Table 66. Bio-Techne Company Summary
Table 67. Bio-Techne Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 68. Bio-Techne Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Bio-Techne Key News & Latest Developments
Table 70. Arigo Biolaboratories Corp. Company Summary
Table 71. Arigo Biolaboratories Corp. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 72. Arigo Biolaboratories Corp. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Arigo Biolaboratories Corp. Key News & Latest Developments
Table 74. Cayman Chemical Company Summary
Table 75. Cayman Chemical Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 76. Cayman Chemical Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Cayman Chemical Key News & Latest Developments
Table 78. Merck Company Summary
Table 79. Merck Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 80. Merck Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Merck Key News & Latest Developments
Table 82. Enzo Life Sciences, Inc. Company Summary
Table 83. Enzo Life Sciences, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 84. Enzo Life Sciences, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Enzo Life Sciences, Inc. Key News & Latest Developments
Table 86. GeneTex Company Summary
Table 87. GeneTex Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 88. GeneTex Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. GeneTex Key News & Latest Developments
Table 90. Wuhan Fine Biotech Co., Ltd. Company Summary
Table 91. Wuhan Fine Biotech Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 92. Wuhan Fine Biotech Co., Ltd. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
Table 94. MyBiosource, Inc. Company Summary
Table 95. MyBiosource, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 96. MyBiosource, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. MyBiosource, Inc. Key News & Latest Developments
Table 98. Biocare Medical, LLC Company Summary
Table 99. Biocare Medical, LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 100. Biocare Medical, LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Biocare Medical, LLC Key News & Latest Developments
Table 102. Abbexa Company Summary
Table 103. Abbexa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 104. Abbexa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Abbexa Key News & Latest Developments
Table 106. Biorbyt Company Summary
Table 107. Biorbyt Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 108. Biorbyt Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Biorbyt Key News & Latest Developments
Table 110. Elabscience Biotechnology Inc. Company Summary
Table 111. Elabscience Biotechnology Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 112. Elabscience Biotechnology Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Elabscience Biotechnology Inc. Key News & Latest Developments
Table 114. Boster Biological Technology Company Summary
Table 115. Boster Biological Technology Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 116. Boster Biological Technology Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 117. Boster Biological Technology Key News & Latest Developments
Table 118. RevMAb Biosciences USA, Inc Company Summary
Table 119. RevMAb Biosciences USA, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 120. RevMAb Biosciences USA, Inc Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 121. RevMAb Biosciences USA, Inc Key News & Latest Developments
Table 122. Abeomics Inc. Company Summary
Table 123. Abeomics Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 124. Abeomics Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 125. Abeomics Inc. Key News & Latest Developments
Table 126. OriGene Technologies, Inc. Company Summary
Table 127. OriGene Technologies, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 128. OriGene Technologies, Inc. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 129. OriGene Technologies, Inc. Key News & Latest Developments
Table 130. Signalway Antibody LLC Company Summary
Table 131. Signalway Antibody LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Offerings
Table 132. Signalway Antibody LLC Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 133. Signalway Antibody LLC Key News & Latest Developments
Table 134. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 135. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Capacity Market Share of Key Manufacturers, 2023-2025
Table 136. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production by Region, 2020-2025 (K Units)
Table 137. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production by Region, 2026-2032 (K Units)
Table 138. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Opportunities & Trends in Global Market
Table 139. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Drivers in Global Market
Table 140. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Restraints in Global Market
Table 141. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Raw Materials
Table 142. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Raw Materials Suppliers in Global Market
Table 143. Typical Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Downstream
Table 144. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Downstream Clients in Global Market
Table 145. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Product Picture
Figure 2. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Segment by Type in 2024
Figure 3. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Segment by Application in 2024
Figure 4. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue: 2020-2032 (US$, Mn)
Figure 8. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue in 2024
Figure 10. Segment by Type � Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 21. By Region - Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
Figure 22. By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 23. By Country - North America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
Figure 24. United States Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
Figure 29. Germany Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 30. France Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales Market Share, 2020-2032
Figure 38. China Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 42. India Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue Market Share, 2020-2032
Figure 44. By Country - South America Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, Market Share, 2020-2032
Figure 45. Brazil Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Sales, Market Share, 2020-2032
Figure 49. Turkey Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Revenue, (US$, Mn), 2020-2032
Figure 53. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody by Region, 2024 VS 2032
Figure 55. Prostaglandin-endoperoxide Synthase 2 (COX-2) Antibody Industry Value Chain
Figure 56. Marketing Channels
